International Programs and Export Development

From the start, companies in the health science sector must take a global approach to doing business. Introducing products to foreign markets, getting key regulatory approvals, and protecting your intellectual property are all considerations that must go into growing your business. The Indiana Health Industry Forum offers a wide variety of programs, partnerships, and resources to help our members become and remain internationally competitive. Let IHIF help you meet the challenges of running a global business head-on.


Translation	Currency Conversion	Trade Finance	U.S. Export Programs
http://translate.google.com/	http://www.oanda.com	http://www.tradeacceptance.com/	http://export.gov/

HS Code Search			FedEx Shipping Discount
http://export.gov/logistics/eg_main_018119.asp	Have a service to help exporters? Advertise here $25/3 months Contact IHIF for more info.		Available to IHIF Members BIO Business Solutions FedEx Express^® international: Up to 35% savings on select services



Australia is the world's second leading source of innovation in the health sciences, behind Europe and in front of the US. However, due to the limited size of the market, from both a population, talent, and financial resource standpoint, Australian companies quickly have to grow into larger markets. The Indiana Health Industry Forum works with a contractor in Australia to provide export development services and in-market research. Project fees are assessed on an hourly basis. Services are available to members and non-members. Interested in finding partners or suppliers in Australia? Need more information on the Australian market? IHIF also helps Australian companies find service and manufacturing partners in Indiana and works with the state's economic development community to respond to investment inquiries. Contact IHIF for more information.
Ausbiotech	AusBiotech is Australia’s industry organisation, working on behalf of members for more than 25 years to provide representation and services to promote the global growth of Australian biotechnology. AusBiotech is a well-connected network of over 3,000 members in the life sciences, including therapeutics, medical technology (devices and diagnostics), food technology and agricultural, environmental and industrial sectors.
University of New South Wales: Technology Transfer Office

Melbourne Life Sciences at a Glance - Melbourne's expertise in stem cell, infectious diseases, cancer, neuroscience and agricultural biotechnology is internationally recognised.
SGS - An Overview of Australia's Regulatory Process for Medical Devices
Australia's R&D Tax Incentive

	Australia at BIO 2013, April 23-25, Chicago IHIF is working with Ausbiotech to arrange meetings between Indiana and Australian companies.

Australian scientists grow HIV antibodies in cow's milk
Pancreatic stem cells show promise for type 1 diabetes Australian researchers have identified pancreatic stem cells that can be converted into insulin-producing cells and found that the cells' number and capacity to become insulin-producers also appeared to increase in response to pancreatic damage. The findings in PLoS ONE may pave the way for new type 1 diabetes treatments, researchers said. Medical News Today (11/14)



	IHIF and the America China Society of Indiana have partnered to help our members access and be successful in their Chinese business affairs.
	A statutory body established in 1966 under the HKTDC Ordinance (Chapter 1114), the Hong Kong Trade Development Council (HKTDC) is the international marketing arm for Hong Kong-based traders, manufacturers and service providers. Our mission is to create opportunities for Hong Kong companies. With our network of more than 40 offices worldwide, and the city’s natural business advantages, we provide a range of services to help global trade and promote Hong Kong as a platform for doing business with China and throughout Asia.

Medical & Healthcare Equipment Industry in Hong Kong - Report released September 2012
Medical Devices and Supplies Product Catalog (May 2013)

Hong Kong International Medical Devices and Supplies Fair - May 14-16, 2013
Asia Biotech Invest -Connecting Capital with Innovation - Hong Kong - June 3-5, 2013



	UK Trade & Investment (UKTI) works with UK-based businesses to ensure their success in international markets, and encourage the best overseas companies to look to the UK as their global partner of choice. IHIF works with the UKTI office in Chicago to identify partnerships that benefit both Indiana and UK companies.
	An international network of small-medium sized companies and multiplier organizations. Coordinates one-to-one business meeting events. Open to international partner companies.

UK Biopharma and Healthcare Market - Source: UKTI

EuroMedtech 2013 - Dusseldorf, Germany - May 7-8, 2013
BioScotland 2013 - Glasgow, Scotland - April 30, 2013



	The Indiana Health Industry Forum and the Japan America Society of Indiana (JASI) have partnered to assist members of both organizations to further explore opportunities between markets.
	IHIF and JASI work cooperatively with the Japanese External Trade Organization (JETRO), a government-related organization that works to promote mutual trade and investment between Japan and the rest of the world. Originally established in 1958 to promote Japanese exports abroad, JETRO's core focus in the 21st century has shifted toward promoting foreign direct investment into Japan and helping small to medium size Japanese firms maximize their global export potential.

Healthcare Business In Japan	Market updates for the medical device and pharma/biotechnology sectors

Building Bio Bridges - A joint program hosted by IHIF and the Japan-America Society of Indiana. Series Announcement Coming Soon!

Eisai snags FDA nod for blockbuster hopeful Fycompa Eisai scored FDA approval for its new epilepsy drug Fycompa. It's the first seizure drug of its kind--a glutamate receptor antagonist--and a blockbuster hopeful for the Japanese drugmaker, which is aiming for top-three status in the seizure drug market. Analysts have said Fycompa could hit $500 million in sales by 2015 and eventually break the $1 billion blockbuster barrier.